Work

P196 Quantizinghla-class-II (HLACII) peptidomic parameters as immunologically-relevantendophenotypes toimproveimmunogenicity risk prediction for protein therapeutics (“Biologics”) using factor(F) VIII inhibitor development in hemophilia a (HA) as a model

Year: 2017

Type: conference-abstract

Source: Human Immunology

DOI: 10.1016/j.humimm.2017.06.256

Authors: V. Diego, B. Luu, M. Almeida, M. Hofmann, J. Hernandez, A. Morelli, A. Ameri, R. Rajalingam, J. Powell, E. Maraskovsky, J. Blangero, T. Howard

Institutions: The University of Texas Rio Grande Valley, CSL (Australia), Augusta University, University of California, San Francisco, CSL (United States)

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2752869939

Cites:

Cited by:

Related to: 10